Uncommon and emerging targets for NSCLC_Fadlo Khuri, MD; #DDHO2021
2:39
Non Small Cell Lung Cancer
Uncommon and emerging targets for NSCLC_Fadlo Khuri, MD; #DDHO2021
Non Small Cell Lung Cancer Similar Videos
Similar Videos
-
Vivek Subbiah, MD The University of Texas MD Anderson Cancer Center 5Live #ASCO20
6:47
Key Insights on Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial.
-
Update on treatment of unresectable stage III NSCLC_Jeff Bradley, MD, FACR, FASTRO; #DDHO2021
1:18
-
Benjamin Besse, MD, PhD; Gustave Roussy Cancer Campus; 5Live; #IASLC21
6:36
